Assessing the impact of an eHealthResp intervention on antibiotics use
Not Applicable
Completed
- Conditions
- RespiratoryAntibiotic prescribing in respiratory tract infections
- Registration Number
- ISRCTN57694130
- Lead Sponsor
- niversity of Aveiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
Primary care physicians and community pharmacists working exclusively at primary healthcare centres or community pharmacies under the catchment area of Portugal’s Centre Regional Health Administration
Exclusion Criteria
1. Retirement
2. Extended sick leave
3. Not involved in any clinical activity (e.g., are engaged in administrative tasks, analysis, etc)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie eHealthResp's impact on antibiotic prescribing for respiratory tract infections?
How does eHealthResp compare to standard-of-care in reducing inappropriate antibiotic use for acute bronchitis and pneumonia?
Are there specific biomarkers that identify primary care professionals most likely to benefit from eHealthResp training?
What adverse events are associated with eHealthResp implementation in primary health care settings?
What combination strategies or alternative interventions show promise in reducing antibiotic overuse for respiratory infections alongside eHealthResp?